200 related articles for article (PubMed ID: 10592399)
1. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
Cribier B; Asch P; Grosshans E
Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin.
Kanitakis J; Hoyo E; Hermier C; Chouvet B; Thivolet J
Cancer; 1992 Jun; 69(12):2937-41. PubMed ID: 1591687
[TBL] [Abstract][Full Text] [Related]
3. Cases with a spontaneous regression of an infiltrating non-crateriform keratoacanthoma and squamous cell carcinoma with a keratoacanthoma-like component.
Misago N; Takai T; Murata Y; Nagase K; Narisawa Y
J Dermatol; 2014 May; 41(5):430-4. PubMed ID: 24628407
[TBL] [Abstract][Full Text] [Related]
4. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
5. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
Takai T; Misago N; Murata Y
J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
[TBL] [Abstract][Full Text] [Related]
7. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
[TBL] [Abstract][Full Text] [Related]
8. Keratoacanthoma: Update on the Debate.
Nirenberg A; Steinman H; Dixon A
Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
[TBL] [Abstract][Full Text] [Related]
9. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
[TBL] [Abstract][Full Text] [Related]
10. Crater/ulcerated form of infundibular squamous cell carcinoma: A possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma.
Misago N; Inoue T; Nagase K; Tsuruta N; Tara-Hashimoto A; Kimura H; Takahara K; Narita T; Narisawa Y
J Dermatol; 2015 Jul; 42(7):667-73. PubMed ID: 25854192
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
Phillips P; Helm KF
J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
[TBL] [Abstract][Full Text] [Related]
12. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification.
Misago N; Inoue T; Koba S; Narisawa Y
J Dermatol; 2013 Jun; 40(6):443-52. PubMed ID: 23414327
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of S100 protein-positive cells in inflamed and non-inflamed keratoacanthoma and squamous cell carcinoma.
Korenberg R; Penneys NS; Kowalczyk A; Nadji M
J Cutan Pathol; 1988 Apr; 15(2):104-8. PubMed ID: 3372786
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
Biesterfeld S; Josef J
Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
[TBL] [Abstract][Full Text] [Related]
15. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
[TBL] [Abstract][Full Text] [Related]
17. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
Goldenhersh MA; Olsen TG
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases.
Magalhães RF; Cruvinel GT; Cintra GF; Cintra ML; Ismael AP; de Moraes AM
J Cutan Med Surg; 2008; 12(4):163-73. PubMed ID: 18627696
[TBL] [Abstract][Full Text] [Related]
19. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
[TBL] [Abstract][Full Text] [Related]
20. Perforating elastic fibers ('elastic fiber trapping') in the differentiation of keratoacanthoma, conventional squamous cell carcinoma and pseudocarcinomatous epithelial hyperplasia.
Shah K; Kazlouskaya V; Lal K; Molina D; Elston DM
J Cutan Pathol; 2014 Feb; 41(2):108-12. PubMed ID: 24138600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
